Pre-earnings options volume in Quince Therapeutics (QNCX) is normal with calls leading puts 17:1. Implied volatility suggests the market is anticipating a move near 68.7%, or 0c, after results are released. Median move over the past eight quarters is 5.7%.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QNCX: